World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
154
Citations
94864
World Ranking
999
National Ranking
570

Jay H. Hoofnagle publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jay H. Hoofnagle sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 570 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jay H. Hoofnagle D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jay H. Hoofnagle sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 154 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Jay H. Hoofnagle is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on the fields of Medicine and Pharmacology, Toxicology, and Pharmaceutics, contributing significantly to the understanding of drug-induced liver conditions and related liver disease diagnostics and treatments.

The scientist has published extensively in areas such as Pharmacology, Epidemiology, and Hepatology, with additional work in Emergency Medicine and Pathology and Forensic Medicine. Their main topics of study include:

  • Drug-Induced Hepatotoxicity and Protection
  • Liver Disease Diagnosis and Treatment
  • Hepatitis C Virus Research
  • Hepatitis B Virus Studies
  • Poisoning and Overdose Treatments
  • Pharmacogenetics and Drug Metabolism
  • Drug Transport and Resistance Mechanisms

Notable recent publications by Jay H. Hoofnagle include:

  • HLA-B*35:01 and Green Tea-Induced Liver Injury, 2020, Hepatology
  • Liver Injury Associated with Turmeric-A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN], 2022, The American Journal of Medicine
  • Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury, 2021, Clinical Gastroenterology and Hepatology
  • Clinical Features, Outcomes, and HLA Risk Factors Associated with Nitrofurantoin-Induced Liver Injury, 2022, Journal of Hepatology
  • Allopurinol Hepatotoxicity is Associated with Human Leukocyte Antigen Class I Alleles, 2021, Liver International

The frequent coauthors collaborating with Jay H. Hoofnagle include:

  • Robert J. Fontana
  • David E. Kleiner
  • Huiman X. Barnhart
  • Jiezhun Gu
  • Paul H. Hayashi

Publications have appeared in venues such as:

  • UNC Libraries
  • Hepatology
  • Journal of Hepatology
  • The American Journal of Gastroenterology
  • Alimentary Pharmacology & Therapeutics

Jay H. Hoofnagle is a member of the Association of American Physicians, highlighting a recognized standing within the medical research community.

Best Publications

  • International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

    F. Alvarez;P. A. Berg;F. B. Bianchi;L. Bianchi

  • Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

    Arun J. Sanyal;Naga Chalasani;Kris V. Kowdley;Arthur McCullough

  • Classification of chronic hepatitis: diagnosis, grading and staging.

    Valeer J. Desmet;Michael Gerber;Jay H. Hoofnagle;Michael Manns

  • Viral Hepatitis and Liver Disease

    Girish N. Vyas;Jules Dienstag;Jay H. Hoofnagle

  • Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

    A. M. Di Bisceglie;P. Martin;C. Kassianides;M. Lisker-Melman

  • Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.

    Hoofnagle Jh;Mullen Kd;Jones Db;Rustgi

  • THE TREATMENT OF CHRONIC VIRAL HEPATITIS

    Hoofnagle Jh;di Bisceglie Am

  • Helicobacter pylori in Peptic Ulcer Disease

    Tadataka Yamada;John G. Searle;Dennis Ahnen

  • Overweight, obesity, and health risk.

    C. J. Billington;L. H. Epstein;N. J. Goodwin;J. O. Hill

  • Mechanism of action of interferon and ribavirin in treatment of hepatitis C

    Jordan J. Feld;Jay H. Hoofnagle

  • Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents: The TONIC Randomized Controlled Trial

    Joel E. Lavine;Jeffrey B. Schwimmer;Mark L. Van Natta;Jean P. Molleston;Jean P. Molleston

  • Pathogenesis, natural history, treatment, and prevention of hepatitis C.

    Liang Tj;Rehermann B;Seeff Lb;Hoofnagle Jh

  • Management of hepatitis B: 2000--summary of a workshop.

    Anna S. Lok;E.Jenny Heathcote;Jay H. Hoofnagle

  • Hepatitis C: the clinical spectrum of disease.

    J H Hoofnagle

  • Management of Hepatitis B: Summary of a Clinical Research Workshop

    Jay H. Hoofnagle;Edward Doo;T. Jake Liang;Russell Fleischer

  • A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.

    Kittichai Promrat;Glen Lutchman;Gabriel I. Uwaifo;Renee J. Freedman

  • Acute liver failure: Summary of a workshop.

    William M. Lee;Robert H. Squires;Scott L. Nyberg;Edward Doo

  • Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection

    Conry-Cantilena C;VanRaden M;Gibble J;Melpolder J

  • Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.

    J H Hoofnagle;G M Dusheiko;L B Seeff;E A Jones

  • National Institutes of Health Consensus Development Conference panel statement: Management of hepatitis C

    D. W. Powell;B. Z. Abramson;J. A. Balint;S. Belle

Frequent Co-Authors

David E. Kleiner
David E. Kleiner National Institutes of Health
Adrian M. Di Bisceglie
Adrian M. Di Bisceglie Saint Louis University
Theo Heller
Theo Heller National Institutes of Health
T. Jake Liang
T. Jake Liang National Institutes of Health
Marc G. Ghany
Marc G. Ghany National Institutes of Health
Naga Chalasani
Naga Chalasani Indiana University
Robert J. Fontana
Robert J. Fontana University of Michigan–Ann Arbor
Leonard B. Seeff
Leonard B. Seeff National Institutes of Health
Marion G. Peters
Marion G. Peters University of California, San Francisco
James E. Everhart
James E. Everhart National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a career in medicine but want flexible options or different healthcare roles, there are several online degrees and training programs that can help you get started—or advance quickly. These pathways offer alternative routes to entering the healthcare field, often with shorter study times and lower costs than traditional medical school.

For students who wish to pursue advanced nursing practice, the cheapest dnp programs can help you achieve a Doctor of Nursing Practice degree at an affordable price. Those looking to start their nursing career sooner may be interested in lpn online programs, which provide fast-track training to become a Licensed Practical Nurse.

Specializing in mental health? The shortest online pmhnp programs can help you become a Psychiatric Mental Health Nurse Practitioner in less time. Alternatively, those interested in management or administrative roles within healthcare might consider pursuing a health administration degree online for affordable, flexible options.

These diverse programs allow you to tailor your education to your specific interests and career goals in the healthcare sector, without the long commitment required for traditional medical degrees.

Best Scientists Citing Jay H. Hoofnagle

Trending Scientists

Recently Published Articles